Download FREE Sample
Report Overview
Custom antibodies are indispensable tools used by researchers and clinicians in life science research, medicine and diagnostics. These antibodies are designed in laboratories to identify and target a specific antigen of interest with high accuracy and precision that may not be addressed by commercially available antibodies. Antigen synthesis, serum collection, animal immunization (usually in rabbits, mice, or goats), and purification are some of the procedures which are used to produce custom antibodies.
To learn more about this report, download the PDF brochure
Targeted therapeutics drive growth in the custom antibody market
The key factor propelling the custom antibody market growth is the increasing demand for precision medicine and targeted therapeutics. With the growing number of R&D activities and better understanding of the molecular basis of complex diseases like cancer, autoimmune disorders, and infectious diseases, researchers need highly specific antibodies to identify and manipulate disease-related proteins. For instance, in June 2025, BioNTech and BristolMyersSquibb signed a global collaboration to co-develop and co-commercialize BNT327, BioNTech-s PD-L1 VEGF-A next-generation bispecific antibody for multiple solid tumor types.
Custom antibodies have a specific ability to bind precisely to unique epitopes, which can improve the detection in diagnostics and enhance efficacy in therapeutic apare investing more in custom antibody production to support the development of ADCs (antibody-drug conjugates) and other advanced biologics. For example, in December 2022, Merck announced an exclusive license and collaboration agreement with Kelun-Biotech to co-develop seven investigational preclinical antibody-drug conjugates (ADCs) for cancer treatment. This trend not only fuels market demand but also expands the applications of custom antibodies.
Technological innovations and collaborations boost custom antibody efficiency
In the evolving landscape of biotechnology, custom antibodies have emerged as an invaluable tool, propelling technological advancements in the diagnostic and therapeutic areas. One such notable innovation is the use of custom antibodies in phage display technology. This method allows scientists to rapidly screen billions of antibody variants and identify those with optimal binding to a specific target antigen.
Unlike other methods, this method has gained widespread adoption in industry and academic research, as it enhances the speed, scalability, and ability to produce tailored antibodies, which are significant for therapeutic applications. For instance,
- In December 2024, Antibody Solutions received approval to become a CRO for Levena-s Singularity- SAPIEN- Mouse platform, a transgenic animal model which allows researchers to generate high-affinity, human-derived antibodies more efficiently for both therapeutic and diagnostic applications
- In March 2024, Sino Biological, Inc. announced a collaboration with Rapid Novor, Inc. Under this agreement, Sino Biological leveraged Rapid Novors' REmAb monoclonal antibody (mAb) sequencing platform alongside its custom antibody development and production services, providing a seamless pipeline from antibody discovery to delivery
The increasing collaborations among biotech companies and research organizations has improve antibody performanceent process more efficient and reproducible. With the growing number of technological innovations, the barrier to entry for high-quality custom antibody production is being lowered, making it more accessible for a broader range of users in the research and diagnostics field.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global custom antibody market is marked by the presence of established and emerging market players such as Thermo Fisher Scientific Inc.; Abcam plc; Bio-Rad Laboratories, Inc; Creative Biolabs; Merck KGaA; Agilent Technologies Inc; GenScript; Laboratory Corporation of America; Danaher Corporation; Kaneka Eurogentec S.A.; Bio-Techne; and Sino Biological, Inc., among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| ~10% | |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Type, Service, Source, Application, and End-user |
| Regional Scope |
|
| Key Companies Mapped | Thermo Fisher Scientific Inc.; Abcam plc; Bio-Rad Laboratories, Inc; Creative Biolabs; Merck KGaA; Agilent Technologies Inc; GenScript; Laboratory Corporation of America; Danaher Corporation; Kaneka Eurogentec S.A.; Bio-Techne; and Sino Biological, Inc. among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Custom Antibody Market Segmentation
This report by Medi-Tech Insights provides thesize of the global custom antibody market at theregional- and country-level from 2023 to 2030. The report further segments the market based on type, service, source, application, and end-user.
Market Size & Forecast (2023-2030), By Type, USD Million
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Others
Market Size & Forecast (2023-2030), By Service, USD Million
- Antibody Development
- Antibody Production & Purification
- Antibody Fragmentation & Labelling
Market Size & Forecast (2023-2030), By Source, USD Million
- Mice
- Rabbit
- Others
- Oncology
- Infectious Diseases
- Neurology
- Stem cells
- Immunology
- Cardiovascular Diseases
- Others
Market Size & Forecast (2023-2030), By End-user, USD Million
- Hospitals & Clinics
- Academic & Research Institutes
- CRO
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the custom antibody market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the custom antibody market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.
